Avoplacel

DB18659InvestigationalCell transplant therapies

Avoplacel (PLX-R18) is an allogeneic cell therapy under investigation for the treatment of acute radiation syndrome.

Code names
PLX-R18

Resolves to

Compound
UNII79NT7I8J0C

What you can answer from here — as of December 02, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Avoplacel, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In